Boots cannabis announcement won't help majority - experts
Many of the obstacles faced by people wishing to use medicinal cannabis will not change despite the announcement (Nov 16) that high street giant Boots is to start prescribing it.
That’s the view of LJMU criminologists who published the first qualitative, sociological study of the experiences of medicinal cannabis users in the UK.
In a first for a UK high street pharmacy, Boots says it will be offering prescriptions to patients aged 25 and older who have an eligible condition such as chronic pain, anxiety or insomnia.
Cannabis is also commonly sought out to manage health conditions like epilepsy.
Costs 'remain barrier'
However, according to Drs Lindsey Metcalf McGrath and Helen Beckett Wilson of LJMU’s Centre for Crime, Criminalisation and Social Exclusion, many vulnerable children and adults who need cannabis medicine cannot access it, despite the legalisation of the medicinal plant in 2018.
“It may be that having high street names like Boots running the online clinics could improve public awareness that cannabis prescriptions are legal but the private healthcare costs probably will remain a barrier for many,” responded Dr Metcalf McGrath.
People are reliant on private clinics because of the lack of NHS provision. Costs can be prohibitive and patients are still experiencing stigma, and exclusion from some spaces, as well as discrimination or problems with police, landlords and employers because of misinformation and negative stereotypes associated with cannabis.
“Patients remain caught between legal prescribing on the one hand, and the wider criminalisation and stigmatisation of cannabis on the other,” she added.
The pair published The Challenges Facing People Prescribed Cannabis in the UK in The International Journal of Drug Policy in 2023.
